05.30.25 -- The Convergence Of Consumer Wellness And Healthcare

On this week’s Business of Biotech, Yaniv Sneor of Mid Atlantic Bio Angels shares how angel investors evaluate biotech startups. Learn how to craft a winning pitch, avoid investor red flags, and navigate funding timelines. Ideal for early-stage drug developers! Brought to you by Avantor.

Community-based clinical trials enhance diversity, addressing mistrust and access barriers by fostering local partnerships and accessible trial sites for underrepresented communities.

Artificial intelligence is transforming clinical trials, enhancing efficiency, participation, and diversity, particularly within hybrid trial models.

The shift to DCTs promised a future of flexibility, access, and rapid enrollment, yet Sponsors are discovering that making trials more available doesn’t automatically make them more accessible.

Optimizing a drug’s solid form can improve its solubility and bioavailability when further molecular modifications are prohibitive.

Review how a combination of optimizing your process development, and process intensification can help drive the cost of dose down.